MedPath

To Evaluate and study analgesic effect of fentanyl as an additive to intrathecal hyperbaric ropivacaine for lower limb surgery

Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2023/05/052455
Lead Sponsor
Dr. Sarvjeet Kaur
Brief Summary

INTRODUCTION: Spinal anaesthesia has been a widely used, safe and effective form of anaesthesia for lower abdominal and extremity surgeries. Intrathecal ropivacaine as a local anaesthetic drug has been introduced into clinical practice as it meets the desired goals of anaesthesia while minimizing the potential side effects. The addition of different adjuvants along with local anaesthetic has shown to have synergistic effect by prolonging the analgesic property and the duration of sensory-motor blockade and decreasing the dose requirement of local anaesthetic. Fentanyl in this regard has also shown some promising effects. The addition of intrathecal fentanyl to ropivacaine may improve the quality of block and early postoperative mobility. Thus we compare the use of ropivacaine along with an adjunct (fentanyl) versus a single agent to attain the desired anesthetic effect while minimizing the associated side effects.

AIMS AND OBJECTIVES: Our aim is to compare analgesic efficacy of intrathecal ropivacaine with fentanyl versus ropivacaine alone in lower limb surgeries.We will compare the onset and duration of sensory blockade and motor blockade and maximum height of sensory blockade achieved. We will also look for safety and side effects, if any in both the groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria
  • 1.Patients scheduled for elective lower limb surgeries under spinal anaesthesia.
  • 2.Patients aged between 18-60 years of either gender, giving valid informed and written consent.
  • 3.Patients belonging to American Society of Anaesthesiology (ASA) grade I and II.
Exclusion Criteria

1.Patient with Known allergy to drugs used in study 2.Any contraindications to spinal anaesthesia 3.Coagulopathy and bleeding diathesis 4.Patients diagnosed with psychiatric ailments 5.History of drug/substance abuse 6.Patients on anti arrhythmic treatment BMI>35 kg/m2.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To study duration of analgesia with intrathecal ropivacaine in lower limb surgery.Outcome will be assessed at the end of study that is 12 months
2.To study duration of analgesia with intrathecal ropivacaine and fentanyl in lower limb surgery.Outcome will be assessed at the end of study that is 12 months
3.To compare duration of analgesia with intrathecal ropivacaine versus intrathecal ropivacaine with fentanyl in lower limb surgery.Outcome will be assessed at the end of study that is 12 months
Secondary Outcome Measures
NameTimeMethod
NANA

Trial Locations

Locations (1)

GGSMCH

🇮🇳

Faridkot, PUNJAB, India

GGSMCH
🇮🇳Faridkot, PUNJAB, India
Dr AASHIMA MAHAJAN
Principal investigator
7009055386
aashimamahajan89@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.